Commentary: Tumor suppressor p53 regulates heat shock factor 1 protein degradation in Huntington’s disease

Huntington’s disease (HD) is a rare, inherited neurodegenerative disorder marked by progressive motor impairment, cognitive decline, and psychiatric disturbances. Increasing evidence implicates dysregulated cellular stress responses in HD pathogenesis, particularly involving the antagonistic interplay between the transcription factors p53 and heat shock factor 1 (HSF1)—key regulators of both cancer biology and neurodegeneration. This commentary highlights recent findings by Mansky et al., which uncover a novel mechanism whereby mutant huntingtin (mtHTT) stabilizes p53, triggering the degradation of HSF1 in striatal neurons. This mechanistic link offers new insight into how disrupted proteostasis drives neuronal vulnerability in HD, highlighting the p53–HSF1 axis as a promising therapeutic target. Additionally, we examine evidence that similar regulatory dynamics may contribute to other neurodegenerative diseases, such as Parkinson’s and Alzheimer’s, suggesting a potentially conserved molecular pathway underlying neuronal degeneration in rare disorders. These findings underscore the therapeutic potential of modulating stress-responsive transcriptional networks to slow or prevent disease progression in HD and related conditions.